Jonathan Sockolosky, PhD

Senior Director, CSO Partner Team at Curie.Bio

Speaker

Jonathan Sockolosky is currently a Senior Director on the CSO Partner Team at Curie.Bio, a founder-centric, therapeutics-focused venture capital firm. Previously, Jonathan was a Principal Scientist and Group Leader in the Department of Antibody Engineering at Genentech. His group focused on the development of next generation immune modulating therapeutics for oncology and cancer immunology, with a focus on cytokine biology and engineering. Prior to Genentech, Jonathan was a Principal Scientist at ALX Oncology, a clinical stage biotechnology company developing CD47/SIRPa antagonists for cancer immunotherapy. Jonathan received his BS/MS in Biomedical Engineering from the University of Michigan, his PhD in Pharmaceutical Sciences from UCSF, and did postdoctoral research at Stanford in the lab of K. Christopher Garcia where he invented orthogonal IL-2 cytokine-receptor pairs for cell therapy under development by Synthekine.